GQG Partners LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 53,092 shares of the company’s stock, valued at approximately $6,822,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MKGAF. Danske Bank A S purchased a new position in shares of Merck KGaA in the 2nd quarter valued at approximately $276,535,000. Korea Investment CORP acquired a new position in shares of Merck KGaA in the second quarter valued at approximately $239,191,000. Great Lakes Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter worth approximately $183,444,000. Ieq Capital LLC acquired a new stake in shares of Merck KGaA during the second quarter worth $102,699,000. Finally, Tocqueville Asset Management L.P. acquired a new stake in shares of Merck KGaA during the second quarter worth $57,546,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
Shares of MKGAF opened at $163.21 on Friday. The stock has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company’s fifty day moving average is $162.62 and its two-hundred day moving average is $148.46.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
